Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management

Ожирение и рак: современный обзор эпидемиологии, патогенеза, исходов и лечения
Sukanya Pati, Wadeed Irfan, Ahmed Tariq Jameel, Shahid Ahmed, Rabia Shahid
2023-01-12

adipokines and chronic inflammationbariatric surgerycancer epidemiologycancer-specific mortalityobesity-associated cancer
BACKGROUND: Obesity or excess body fat is a major global health challenge that has not only been associated with diabetes mellitus and cardiovascular disease but is also a major risk factor for the development of and mortality related to a subgroup of cancer. This review focuses on epidemiology, the relationship between obesity and the risk associated with the development and recurrence of cancer and the management of obesity. METHODS: A literature search using PubMed and Google Scholar was performed and the keywords 'obesity' and cancer' were used. The search was limited to research papers published in English prior to September 2022 and focused on studies that investigated epidemiology, the pathogenesis of cancer, cancer incidence and the risk of recurrence, and the management of obesity. RESULTS: About 4-8% of all cancers are attributed to obesity. Obesity is a risk factor for several major cancers, including post-menopausal breast, colorectal, endometrial, kidney, esophageal, pancreatic, liver, and gallbladder cancer. Excess body fat results in an approximately 17% increased risk of cancer-specific mortality. The relationship between obesity and the risk associated with the development of cancer and its recurrence is not fully understood and involves altered fatty acid metabolism, extracellular matrix remodeling, the secretion of adipokines and anabolic and sex hormones, immune dysregulation, and chronic inflammation. Obesity may also increase treatment-related adverse effects and influence treatment decisions regarding specific types of cancer therapy. Structured exercise in combination with dietary support and behavior therapy are effective interventions. Treatment with glucagon-like peptide-1 analogues and bariatric surgery result in more rapid weight loss and can be considered in selected cancer survivors. CONCLUSIONS: Obesity increases cancer risk and mortality. Weight-reducing strategies in obesity-associated cancers are important interventions as a key component of cancer care. Future studies are warranted to further elucidate the complex relationship between obesity and cancer with the identification of targets for effective interventions.
1
Approximately 4–8% of all cancers are attributed to obesity, which increases risk for several major cancer types.
2
Obesity is associated with an approximately 17% increased risk of cancer-specific mortality.
3
Obesity may increase treatment-related adverse effects and influence decisions about specific cancer therapies.
4
Obesity-related carcinogenesis and recurrence involve altered fatty acid metabolism, extracellular matrix remodeling, adipokine and hormone secretion, immune dysregulation, and chronic inflammation.
5
Structured exercise combined with dietary support and behavioral therapy is effective for weight management; GLP-1 analogues and bariatric surgery may be considered for selected cancer survivors.

Obesity and obesity-associated cancers

The epidemiology, pathogenesis, cancer incidence and recurrence risk, mortality, and management of obesity-associated cancers

Publication Details
Publication Date
2023-01-12
Journal
Publisher
ISSN
Cited by
655
Access Type
Author Information
Authors
Sukanya Pati
Wadeed Irfan
Ahmed Tariq Jameel
Shahid Ahmed
Rabia Shahid
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat
Make a presentation
100%